· Daily · Newsletters
Resonance network: Quantum InsiderSpace Insider
Insider Brief PRESS RELEASE — Insilico Medicine(“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has announced the close of its Series E financing round at a total of around $123 million, surpassing
The daily briefing on LinkedIn. Free, one tap to follow.
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.